Sinopharm Hyundai announced that Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration to approve acetaminophen tablets to pass a consistent evaluation of the quality and efficacy of generic drugs. Acetaminophen tablets are mainly suitable for fever caused by the common cold or influenza, and are also used to relieve mild to moderate pain, such as headache, joint pain, migraine, toothache, muscle pain, neuralgia, and dysmenorrhea. According to the Miintranet database, sales of acetaminophen tablets in public medical institutions and urban pharmacies across the country in 2025 were RMB 86.17 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.